Payal Banerjee And Barun Jha

Stories by Payal Banerjee And Barun Jha

Hackers demand Rs 200 cr to restore AIIMS servers, data of 4 crore patients at stake

Hackers demand Rs 200 cr to restore AIIMS servers, data of 4 crore patients at stake

Rediff.com   28 Nov 2022

It is feared that data of around 3-4 crore patients could have been compromised due to the breach detected Wednesday morning.

Experts feel COVID-19 has reached endemic phase

Experts feel COVID-19 has reached endemic phase

Rediff.com   30 Oct 2022

According to some experts, there is not much difference in the number of seasonal flu cases and that of COVID-19, even though they stressed that surveillance for newer variants should continue in the off chance of a new lineage of coronavirus catching the country off guard.

Centre not to procure fresh Covid vaccines; surrenders budget

Centre not to procure fresh Covid vaccines; surrenders budget

Rediff.com   16 Oct 2022

The government's Covid vaccination programme is in its final leg with the health ministry deciding against procuring more vaccines as of now and surrendering Rs 4,237 crore, or nearly 85 per cent of the 2022-23 budget allocation for inoculation purposes, to the finance ministry.

Monkeypox case in Delhi takes India's tally to 4; govt holds high-level meet

Monkeypox case in Delhi takes India's tally to 4; govt holds high-level meet

Rediff.com   24 Jul 2022

The man had attended a stag party recently in Manali in Himachal Pradesh.

Monkeypox: Experts allay fears, say disease less contagious and rarely fatal

Monkeypox: Experts allay fears, say disease less contagious and rarely fatal

Rediff.com   24 Jul 2022

According to these experts, a monkeypox outbreak can effectively be tackled by strong surveillance.

Free Covid booster for below 60 from July 15

Free Covid booster for below 60 from July 15

Rediff.com   13 Jul 2022

So far, less than 1 per cent of the target population of 77 crore in the 18-59 age group have been administered the precaution dose.

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

Rediff.com   28 Jun 2022

The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years.

PM-led panel seeks wider panel of names for next AIIMS-Delhi chief: Sources

PM-led panel seeks wider panel of names for next AIIMS-Delhi chief: Sources

Rediff.com   21 Jun 2022

The tenure of the incumbent AIIMS director, Dr Randeep Guleria, which was set to end on March 24, was extended by three months.

Govt panel recommends reducing Covid booster dose gap to 6 months

Govt panel recommends reducing Covid booster dose gap to 6 months

Rediff.com   16 Jun 2022

The Standing Technical Sub-Committee (STSC) of the National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended reducing the gap between the second and precaution doses of COVID-19 vaccines from the current nine to six months, official sources said.

Govt to repurpose CoWIN to include all vaccination

Govt to repurpose CoWIN to include all vaccination

Rediff.com   27 May 2022

The Universal Immunisation Programme is one of the largest vaccination projects in the world aimed at protecting children and pregnant mothers from preventable diseases. Under it, the government provides shots for 12 vaccine-preventable diseases, such as polio, diphtheria, tetanus, measles, and hepatitis B, for free.

Advanced economies to be back on track by 2024: IMF's Gita Gopinath

Advanced economies to be back on track by 2024: IMF's Gita Gopinath

Rediff.com   25 May 2022

Advanced economies will be back on track by 2024, but developing economies will be 5 per cent below where they would have been otherwise, IMF's Gita Gopinath said on Wednesday. Economies worldwide have been adversely impacted by the coronavirus pandemic and are slowly coming back into the recovery path. The First Deputy Managing Director of the International Monetary Fund said the war in Ukraine has been a major setback to the global recovery.

'Profiting from Pain': Covid created new billionaire every 30 hrs

'Profiting from Pain': Covid created new billionaire every 30 hrs

Rediff.com   23 May 2022

Releasing a report titled 'Profiting from Pain' in Davos, the rights group further said as the cost of essential goods rises faster than it has in decades, billionaires in the food and energy sectors are increasing their fortunes by $1 billion every two days.

Monkeypox outbreak: Govt alerts agencies, asks them to keep vigil

Monkeypox outbreak: Govt alerts agencies, asks them to keep vigil

Rediff.com   20 May 2022

The Union health ministry has also directed airport and port health officers to be vigilant, they said.

India likely to reduce Covid booster gap to 6 months, decision on Friday

India likely to reduce Covid booster gap to 6 months, decision on Friday

Rediff.com   27 Apr 2022

The government is likely to soon reduce the gap between the second dose of Covid-19 vaccine and the precaution dose from the current nine months to six months, official sources said on Wednesday.

Future Covid waves unlikely to have serious impact in India: Experts

Future Covid waves unlikely to have serious impact in India: Experts

Rediff.com   20 Mar 2022

The reason is that because of the hybrid immunity after three waves of natural infection and a large proportion of adults receiving both doses of COVID-19 vaccine, the susceptible pool has come down drastically, Lahariya said.

Govt to hold meet as Indians studying in Ukraine worried about future

Govt to hold meet as Indians studying in Ukraine worried about future

Rediff.com   1 Mar 2022

"As of now, there are no norms and regulations under the National Medical Commission to accommodate medical students, who were studying abroad and had to return to India midway, in Indian medical colleges in between an academic session," a health ministry official told PTI, on the condition of anonymity.

NSE co-location case: Probe shifts towards money trail, illicit gains

NSE co-location case: Probe shifts towards money trail, illicit gains

Rediff.com   21 Feb 2022

As a multi-agency probe into the NSE case gathers pace, the grant of preferential server and data access to select brokers and their suspected misuse are being investigated threadbare to unveil all quid pro quo arrangements in a highly-sophisticated scheme that worked like a cricket betting scandal, officials said on Monday. While the bourse has said it has taken several steps over the years to strengthen its technology infrastructure, including as per regulatory orders, the officials said certain fresh disclosures call for a detailed probe into whether a select group of individuals in high positions had banded together to make illicit gains by facilitating the preferential trading slots, beginning over a decade ago. Even a split-second faster access is said to result in huge gains for a trader.

Covishield, Covaxin get regular market approval

Covishield, Covaxin get regular market approval

Rediff.com   27 Jan 2022

Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting.Adverse event following immunisation will continue to be monitored.

Govt panel recommends regular market approval for Covishield, Covaxin

Govt panel recommends regular market approval for Covishield, Covaxin

Rediff.com   20 Jan 2022

An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to COVID vaccines Covishield and Covaxin for use in adult population subject to certain conditions, official sources said.

Molnupiravir not to be included in Covid treatment now

Molnupiravir not to be included in Covid treatment now

Rediff.com   11 Jan 2022

The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now, official sources said on Tuesday.